Ardent Health Partners/$ARDT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Ardent Health Partners
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in services and technologies, Ardent is passionate about making healthcare easier to access.
Ticker
$ARDT
Sector
Primary listing
NYSE
Employees
22,050
Headquarters
Website
ARDT Metrics
BasicAdvanced
$2.1B
7.94
$1.81
-
-
Price and volume
Market cap
$2.1B
52-week high
$17.34
52-week low
$10.10
Average daily volume
338K
Financial strength
Current ratio
2.131
Quick ratio
1.475
Long term debt to equity
136.977
Total debt to equity
138.169
Interest coverage (TTM)
7.58%
Profitability
EBITDA (TTM)
582.458
Gross margin (TTM)
57.76%
Net profit margin (TTM)
4.11%
Operating margin (TTM)
6.97%
Effective tax rate (TTM)
18.77%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
5.61%
Return on equity (TTM)
24.32%
Valuation
Price to earnings (TTM)
7.944
Price to revenue (TTM)
0.324
Price to book
1.64
Price to tangible book (TTM)
6.87
Price to free cash flow (TTM)
18.576
Free cash flow yield (TTM)
5.38%
Free cash flow per share (TTM)
0.775
Growth
Revenue change (TTM)
10.03%
Earnings per share change (TTM)
918.26%
Bulls say / Bears say
Ardent Health posted 11.9% year-over-year revenue growth to $1.65 billion and a 38.9% increase in adjusted EBITDA to $170 million for Q2 2025, underlining robust demand and operating leverage. (Business Wire)
Ardent successfully amended and extended its $777.5 million term loan facility in September 2025, cutting the interest rate by 50 basis points to SOFR + 2.25% and reducing annual interest expense by approximately $3.9 million, improving its capital flexibility. (Business Wire)
S&P Global upgraded Ardent's issuer credit rating from B to B+ in April 2025, based on improved credit metrics and lower leverage, which should support more favorable borrowing costs. (Investing.com)
Outpatient surgeries declined 2.3% in Q1 2025, weighing on total surgical volume and pointing to potential challenges for ambulatory services growth. (Business Wire)
BofA Securities downgraded ARDT to Underperform in July 2025, citing expected headwinds from Medicaid and ACA cutbacks that could dampen volume growth and increase bad debt. (Investing.com)
Management highlighted continued payer denial challenges in Q2 2025, signifying ongoing reimbursement pressures that could limit margin expansion. (Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 8 Nov 2025.
ARDT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ardent Health Partners stock?
Ardent Health Partners (ARDT) has a market cap of $2.1B as of November 09, 2025.
What is the P/E ratio for Ardent Health Partners stock?
The price to earnings (P/E) ratio for Ardent Health Partners (ARDT) stock is 7.94 as of November 09, 2025.
Does Ardent Health Partners stock pay dividends?
No, Ardent Health Partners (ARDT) stock does not pay dividends to its shareholders as of November 09, 2025.
When is the next Ardent Health Partners dividend payment date?
Ardent Health Partners (ARDT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ardent Health Partners?
Ardent Health Partners (ARDT) does not currently have a Beta indicator.